Clinical trial
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever…
NCT00003805 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003805 |
|---|---|
| Title | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count |
| Official title | Vancomycin Versus Placebo in Persistently Febrile Granulocytopenic Patients Given Piperacillin/Tazobactam |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bone Marrow Suppression, Fever, Sweats, and Hot Flashes, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Unspecified Adult Solid Tumor and 2 more |
| Intervention type | Drug |
| Interventions | piperacillin sodium, piperacillin-tazobactam, tazobactam sodium, vancomycin |
| Enrollment | 859 |
| Start date | Nov 1, 1997 |
| Primary completion | Jun 1, 2000 |
| First posted | Jul 16, 2004 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, Canada, Czechia, Finland, France, Germany, Greece, Israel, Slovakia, Switzerland, Turkey (Türkiye), United Kingdom and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: